Literature DB >> 9824268

Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

J Córdoba1, J Gottstein, A T Blei.   

Abstract

BACKGROUND/AIM: Abnormalities in brain organic osmolytes are associated with hepatic encephalopathy and with chronic hyponatremia. In spite of the high frequency of hyponatremia in acute and chronic hepatic failure, its role in the development of neurological complications in liver disease is poorly understood. We aimed to study the effect of prior hyponatremia on the development of ammonia-induced brain edema in rats after portacaval anastomosis. In this model, brain swelling is mediated in part through an increase in brain glutamine, an organic osmolyte.
METHODS: Hyponatremia was induced in rats with 1-desamino-8-D-arginine vasopressin (DDAVP) administered through an osmotic minipump for 1 week. This was followed by performance of a portacaval anastomosis and ammonia infusion. At the end of the infusion, brain water (density gradient) and key brain organic osmolytes (HPLC) were measured.
RESULTS: Rats with hyponatremia showed a decrease in all three brain organic osmolytes measured: glutamine, myo-inositol and taurine. Hyperammonemia resulted in the expected rise in glutamine, with a reduction of myo-inositol and taurine. In the combined group (hyponatremia plus hyperammonemia), the rise in brain glutamine induced by ammonia infusion was attenuated (10.6+/-0.9 mM/kg vs. 15.5+/-0.8 mM/kg hyperammonemia alone; p<0.05). In spite of this limited rise in brain glutamine, ammonia infusion to hyponatremic rats exacerbated brain swelling (82.3+/-0.3% vs. 80.6+/-0.1%; p<0.05).
CONCLUSIONS: Hyponatremia worsens brain swelling in a model of ammonia-induced brain edema. The decrease in the concentration of brain organic osmolytes induced by hyponatremia does not protect the brain from the development of ammonia-induced brain edema.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824268     DOI: 10.1016/s0168-8278(98)80154-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  26 in total

Review 1.  Therapy of intracranial hypertension in patients with fulminant hepatic failure.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

Review 3.  Management in acute liver failure.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2014-12-03

Review 4.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

5.  Hepatic encephalopathy therapy: An overview.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

Review 6.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

Review 7.  Systemic inflammation and ammonia in hepatic encephalopathy.

Authors:  Thomas H Tranah; Godhev K Manakkat Vijay; Jennifer M Ryan; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2012-12-07       Impact factor: 3.584

Review 8.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

9.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

Authors:  Maria-Carlota Londoño; Andrés Cárdenas; Mónica Guevara; Llorenç Quintó; Dara de Las Heras; Miguel Navasa; Antoni Rimola; Juan-Carlos Garcia-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

Review 10.  Acute liver failure.

Authors:  Ludwig Kramer
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.